J&J China Enters Medical Device Market With Bioseal Buy

Law360, New York (May 2, 2012, 6:48 PM EDT) -- In its first acquisition in the medical device industry, Johnson & Johnson (China) Investment Ltd. scooped up a Chinese biopharmaceutical company that makes a protein sealant used to control bleeding during surgery, the health care giant announced Wednesday.

The deal gives New Jersey-based Johnson & Johnson the privately held Guangzhou Bioseal Biotech Co. Ltd., headquartered in China's Guangdong province, according to a statement Johnson & Johnson issued Wednesday.

The buyer did not disclose the terms of the deal. Representatives for the parties were not immediately available...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.